Related Experiment Videos
Developing nonsteroidal anti-inflammatory drugs (NSAIDs) with decreased gastrointestinal (GI) toxicity
B Goldlust1, M Doucette, C Verduyn
1Clinical Research, 3M Pharmaceuticals, St. Paul, MN 55144.
Agents and Actions. Supplements
|January 1, 1991
Abstract:
NSAID-induced gastropathy is an important iatrogenic disorder that must be addressed in the development of NSAIDs. A scheme for clinical evaluation is described and salsalate is discussed as a prototype.